[go: up one dir, main page]

GB9822945D0 - Epibatidine analogues - Google Patents

Epibatidine analogues

Info

Publication number
GB9822945D0
GB9822945D0 GBGB9822945.3A GB9822945A GB9822945D0 GB 9822945 D0 GB9822945 D0 GB 9822945D0 GB 9822945 A GB9822945 A GB 9822945A GB 9822945 D0 GB9822945 D0 GB 9822945D0
Authority
GB
United Kingdom
Prior art keywords
epibatidine analogues
epibatidine
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9822945.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9822945.3A priority Critical patent/GB9822945D0/en
Publication of GB9822945D0 publication Critical patent/GB9822945D0/en
Priority to EP99949136A priority patent/EP1123277A1/en
Priority to JP2000577152A priority patent/JP2002527506A/en
Priority to PCT/GB1999/003175 priority patent/WO2000023424A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB9822945.3A 1998-10-20 1998-10-20 Epibatidine analogues Ceased GB9822945D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9822945.3A GB9822945D0 (en) 1998-10-20 1998-10-20 Epibatidine analogues
EP99949136A EP1123277A1 (en) 1998-10-20 1999-09-22 Epibatidine analogues as acetylcholine receptor antagonists
JP2000577152A JP2002527506A (en) 1998-10-20 1999-09-22 Epibatidine analogs as acetylcholine receptor antagonists
PCT/GB1999/003175 WO2000023424A1 (en) 1998-10-20 1999-09-22 Epibatidine analogues as acetylcholine receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822945.3A GB9822945D0 (en) 1998-10-20 1998-10-20 Epibatidine analogues

Publications (1)

Publication Number Publication Date
GB9822945D0 true GB9822945D0 (en) 1998-12-16

Family

ID=10840943

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9822945.3A Ceased GB9822945D0 (en) 1998-10-20 1998-10-20 Epibatidine analogues

Country Status (4)

Country Link
EP (1) EP1123277A1 (en)
JP (1) JP2002527506A (en)
GB (1) GB9822945D0 (en)
WO (1) WO2000023424A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10044905A1 (en) 2000-09-12 2002-03-21 Merck Patent Gmbh (2-Azabicyclo [2.2.1] hept-7-yl) methanol derivatives as nicontinic acetylcholine receptor agonists
DE10118551A1 (en) * 2001-04-14 2002-10-17 Merck Patent Gmbh New 2-aza-bicyclo (2.2.1) heptane derivatives, are nicotinic acetyl choline receptor ligands useful for e.g. treating schizophrenia, depression or neurodegenerative diseases
US6921402B2 (en) 2001-12-27 2005-07-26 Ethicon, Inc. Polymer-based orthopedic screw and driver system with increased insertion torque tolerance and associated method for making and using same
ES2356356T3 (en) 2003-10-15 2011-04-07 Targacept, Inc. AZABICYCLIC COMPOUNDS TO RELIEF PAIN AND TREAT THE DISORDERS OF THE CENTRAL NERVOUS SYSTEM.
CA2638573C (en) 2008-04-30 2013-03-12 Universiteit Gent Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
US8389561B2 (en) 2008-04-30 2013-03-05 Universiteit Gent Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
US8809365B2 (en) 2009-11-04 2014-08-19 Universiteit Gent 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020051D0 (en) * 1990-09-13 1990-10-24 Pfizer Ltd Muscarinic receptor antagonists
US5442059A (en) * 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
AU701227B2 (en) * 1993-09-10 1999-01-21 Cytomed, Inc Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
WO1998048801A1 (en) * 1997-04-26 1998-11-05 Sumitomo Pharmaceuticals Co., Ltd. 2-azabicyclo compounds

Also Published As

Publication number Publication date
JP2002527506A (en) 2002-08-27
EP1123277A1 (en) 2001-08-16
WO2000023424A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59903023D1 (en) Perorale wirkstoff-suspension
DE69904442D1 (en) Cyclohexandiol-derivate
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
AU136492S (en) Canister
GB2337549B (en) Retaining components
GB9822945D0 (en) Epibatidine analogues
GB9808914D0 (en) Grassboards
GB9814620D0 (en) Vasculoprotector
GB9814916D0 (en) Easy-carry
GB2336996B (en) Multi-desk
GB9809301D0 (en) Aquaplug
DE59905941D1 (en) Methoximinophenylessigsäureamide
GB9803582D0 (en) Post-protectors
GB9814571D0 (en) Tri-ball
GB9817832D0 (en) Curvers
GB9804461D0 (en) Foaming component
GB9801641D0 (en) Carboximeter
GB9824111D0 (en) Sawbench
GB2340044B (en) Co-Stitcher
AU137998S (en) Violincello endpin rest
GB9804647D0 (en) Epiwarn (electro-encepalo-feedback)
TW365933U (en) Anti-electrostatic structure
GB9817869D0 (en) Trims

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)